AAAAAA
Results:
1-12
|
Results: 12
Authors:
Ruiz, L
Carcelain, G
Martinez-Picado, J
Frost, S
Marfil, S
Paredes, R
Romeu, J
Ferrer, E
Morales-Lopetegi, K
Autran, B
Clotet, B
Citation: L. Ruiz et al., HIV dynamics and T-cell immunity after three structured treatment interruptions in chronic HIV-1 infection, AIDS, 15(9), 2001, pp. F19-F27
Authors:
Gilbert, PB
Hanna, GJ
De Gruttola, V
Martinez-Picado, J
Kuritzkes, DR
Johnson, VA
Richman, DD
D'Aquila, RT
Citation: Pb. Gilbert et al., Comparative analysis of HIV type 1 genotypic resistance across antiretroviral trial treatment regimens, AIDS RES H, 16(14), 2000, pp. 1325-1336
Authors:
Ruiz, L
Martinez-Picado, J
Romeu, J
Paredes, R
Zayat, MK
Marfil, S
Negredo, E
Sirera, G
Tural, C
Clotet, B
Citation: L. Ruiz et al., Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppression, AIDS, 14(4), 2000, pp. 397-403
Authors:
Miller, V
Sabin, C
Hertogs, K
Bloor, S
Martinez-Picado, J
D'Aquila, R
Larder, B
Lutz, T
Gute, P
Weidmann, E
Rabenau, H
Phillips, A
Staszewski, S
Citation: V. Miller et al., Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failure, AIDS, 14(18), 2000, pp. 2857-2867
Authors:
Hanna, GJ
Johnson, VA
Kuritzkes, DR
Richman, DD
Martinez-Picado, J
Sutton, L
Hazelwood, JD
D'Aquila, RT
Citation: Gj. Hanna et al., Comparison of sequencing by hybridization and cycle sequencing for genotyping of human immunodeficiency virus type 1 reverse transcriptase, J CLIN MICR, 38(7), 2000, pp. 2715-2721
Authors:
Martinez-Picado, J
Savara, AV
Shi, L
Sutton, L
D'Aquila, RT
Citation: J. Martinez-picado et al., Fitness of human immunodeficiency virus type 1 protease inhibitor-selectedsingle mutants, VIROLOGY, 275(2), 2000, pp. 318-322
Authors:
Martinez-Picado, J
DePasquale, MP
Kartsonis, N
Hanna, GJ
Wong, J
Finzi, D
Rosenberg, E
Gunthard, HF
Sutton, L
Savara, A
Petropoulos, CJ
Hellmann, N
Walker, BD
Richman, DD
Siliciano, R
D'Aquila, RT
Citation: J. Martinez-picado et al., Antiretroviral resistance during successful therapy of HIV type 1 infection, P NAS US, 97(20), 2000, pp. 10948-10953
Authors:
Martinez-Picado, J
Sutton, L
De Pasquale, MP
Savara, AV
D'Aquila, RT
Citation: J. Martinez-picado et al., Human immunodeficiency virus type 1 cloning vectors for antiretroviral resistance testing, J CLIN MICR, 37(9), 1999, pp. 2943-2951
Authors:
Martinez-Picado, J
Savara, LV
Sutton, L
D'Aquila, RT
Citation: J. Martinez-picado et al., Replicative fitness of protease inhibitor-resistant mutants of human immunodeficiency virus type 1, J VIROLOGY, 73(5), 1999, pp. 3744-3752
Authors:
Arno, A
Ruiz, L
Juan, M
Jou, A
Balague, M
Zayat, MK
Marfil, S
Martinez-Picado, J
Martinez, MA
Romeu, J
Pujol-Borrell, R
Lane, C
Clotet, B
Citation: A. Arno et al., Efficacy of low-dose subcutaneous interleukin-2 to treat advanced human immunodeficiency virus type 1 in persons with <= 250/mu L CD4 T cells and undetectable plasma virus load, J INFEC DIS, 180(1), 1999, pp. 56-60
Authors:
Merrill, DP
Martinez-Picado, J
Tremblay, C
Sax, PE
Boswell, SL
Wong, JT
D'Aquila, RT
Walker, BD
Hirsch, MS
Citation: Dp. Merrill et al., Improved CD4 lymphocyte outgrowth in response to effective antiretroviral therapy, J INFEC DIS, 179(2), 1999, pp. 345-351
Authors:
Clotet, B
Paredes, R
Martinez-Picado, J
Tural, C
Ruiz, L
Citation: B. Clotet et al., It is necessary to start with protease inhibitors?, SEVENTH EUROPEAN CONFERENCE ON CLINICAL ASPECTS AND TREATMENT OF HIV-INFECTION, 1999, pp. 9-17
Risultati:
1-12
|